Art

J-GLOBAL ID：202002270989636719   Reference number：20A0783053

Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study

LDLコレステロール標的レベル<1.81mmol/lの達成は,高リスク患者における心血管保護を追加する可能性がある: 高コレステロール血症および糖尿病網膜症研究患者に対する標準的および集中的スタチン療法の探索的分析【JST・京大機械翻訳】

Author (43)： Itoh Hiroshi (Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine, Tokyo, Japan) ,  Komuro Issei (Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan) ,  Takeuchi Masahiro (Department of Clinical Medicine (Biostatistics and Pharmaceutical Medicine), School of Pharmacy, Kitasato University, Tokyo, Japan) ,  Akasaka Takashi (Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan) ,  Daida Hiroyuki (Department of Cardiovascular Medicine, Graduate School of Medicine Juntendo University, Tokyo, Japan) ,  Egashira Yoshiki (Sakura Hospital, Fukuoka, Japan) ,  Fujita Hideo (Department of Cardiology, Saitama Medical Centre, Jichi Medical University, Saitama, Japan) ,  Higaki Jitsuo (Department of Integrated Medicine and Informatics, Ehime University Graduate School of Medicine, Toon, Japan) ,  Hirata Ken-ichi (Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Ishibashi Shun (Division of Endocrinology and Metabolism, Department of Internal Medicine, Jichi Medical University, Shimotsuke, Japan) ,  Isshiki Takaaki (Division of Cardiology, Cardiovascular Centre, Ageo Central General Hospital, Ageo, Japan) ,  Ito Sadayoshi (Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan) ,  Kashiwagi Atsunori (Kusatsu General Hospital, Kusatsu, Japan) ,  Kato Satoshi (Department of Ophthalmology, University of Tokyo Graduate School of Medicine, Tokyo, Japan) ,  Kitagawa Kazuo (Department of Neurology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan) ,  Kitakaze Masafumi (Division of Cardiology, National Cerebral and Cardiovascular Centre, Suita, Japan) ,  Kitazono Takanari (Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan) ,  Kurabayashi Masahiko (Department of Medicine and Biological Science, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Miyauchi Katsumi (Department of Cardiology, Graduate School of Medicine Juntendo University, Tokyo, Japan) ,  Murakami Tomoaki (Department of Ophthalmology, Kyoto University Graduate School of Medicine, Kyoto, Japan) ,  Murohara Toyoaki (Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Node Koichi (Department of Cardiovascular Medicine, Saga University, Saga, Japan) ,  Ogawa Susumu (Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Hospital, Sendai, Japan) ,  Saito Yoshihiko (First Department of Internal Medicine, Nara Medical University, Kashihara, Japan) ,  Seino Yoshihiko (Department of Cardiology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan) ,  Shigeeda Takashi (Ideta Eye Clinic, Kumamoto, Japan) ,  Shindo Shunya (Department of Cardiovascular Surgery, Tokyo Medical University Hachioji Medical Centre, Hachioji, Japan) ,  Sugawara Masahiro (Sugawara Medical Clinic, Tokyo, Japan) ,  Sugiyama Seigo (Department of Cardiology, Jinnouchi Hospital, Kumamoto, Japan) ,  Terauchi Yasuo (Department of Endocrinology and Metabolism, Yokohama City University School of Medicine, Yokohama, Japan) ,  Tsutsui Hiroyuki (Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan) ,  Ueshima Kenji (Department of EBM Research, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan) ,  Utsunomiya Kazunori (Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan) ,  Yamagishi Masakazu (Department of Cardiovascular and Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan) ,  Yamazaki Tsutomu (Clinical Research Support Centre, University of Tokyo Hospital, Tokyo, Japan) ,  Yo Shoei (Yo Clinic, Kyoto, Japan) ,  Yokote Koutaro (Department of Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan) ,  Yoshida Kiyoshi (Sakakibara Heart Institute of Okayama, Okayama, Japan) ,  Yoshimura Michihiro (Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan) ,  Yoshimura Nagahisa (Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka, Japan) ,  Nakao Kazuwa (Medical Innovation Centre, Kyoto University Graduate School of Medicine, Kyoto, Japan) ,  Nagai Ryozo (Jichi Medical University, Shimotsuke, Japan) ,  for the EMPATHY Investigators
Material： Diabetes Obesity & Metabolism
Volume： 21  Issue： 4  Page： 791-800  Publication year： 2019 
JST Material Number： W2549A  ISSN： 1462-8902  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Abstract/Point： AIMS: To assess the benefits o...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0783053&from=J-GLOBAL&jstjournalNo=W2549A") }}

Thesaurus term： *retinopathy ,  *Diabetic Retinopathy ,  hyperlipidemia ,  base line ,  cardiovascular disease ,  *Cardiovascular System ,  clinical trial ,  *LDL cholesterol ,  *hypercholesterolemia ,  Type 2 diabetes mellitus ,  end point ,  Intensive Care ,  *Diabetes Mellitus ,  *complication ,  metabolic disease
Semi thesaurus term： ハザード比 ,  一次予防 ,  *スタチン療法 , 【Automatic Indexing@JST】

Author keywords (5)： cardiovascular disease ,  clinical trial ,  diabetic retinopathy ,  dyslipidaemia ,  lipid-lowering therapy

JST classification (2)： Clinical application of drugs acting on lipid metabolism  (GW13050X) ,  Treatment for metabolic diseases,nutritional diseases.  (GD05030F)

Terms in the title (13)： LDLコレステロール ,  標的 ,  高リスク患者 ,  心血管 ,  可能性 ,  高コレステロール血症 ,  糖尿病網膜症 ,  研究 ,  患者 ,  標準 ,  スタチン療法 ,  探索 ,  分析